PubHawk
Front Endocrinol (Lausanne) January 2022 PMID 34305810

Safety of Semaglutide.

Mark M Smits, Daniël H Van Raalte

Full text PDF Download social card

Mentions

241
Peak: 30 in Dec 2024
across 6 sources since Jul 2021

Extended reach

1,609,744
potential audience

Total likes

3,030

Video views

117,429

Mentions per month

Jul 2021 – Nov 2025

Where it's discussed

  • X / Twitter156 posts
  • News64 articles
  • Bluesky8 posts
  • Blogs6 articles
  • YouTube5 videos
  • Reddit2 posts

AI synopsis

What people are saying

The discussions reveal a balanced concern with safety issues, as seen in posts mentioning side effects like gastrointestinal disturbances, potential risks such as pancreatitis and thyroid cancer, and referencing numerous recent studies, which underscores high interest and active engagement. The tone varies from cautious skepticism to acknowledgment of ongoing research, reflecting the nuanced perceptions about semaglutide's safety profile.

AgreementNeither agree nor disagree

The discussions show mixed opinions; some emphasize safety concerns, while others highlight the benefits and ongoing research, indicating neither full support nor disagreement.

InterestHigh interest

The majority are highly interested, with many posts referencing multiple recent studies, safety updates, and clinical trials related to semaglutide.

EngagementModerate engagement

Posts demonstrate moderate engagement through sharing summaries, personal experiences, and critiques of safety data, reflecting active interest without deep scientific debate.

ImpactModerate impact

While users debate safety risks and its implications, the overall influence appears modest; the discussions could shape perceptions but don't seem to drive significant change yet.

Abstract in brief

  • Semaglutide, a GLP1 receptor agonist available in both injectable and oral forms, effectively improves blood sugar control and promotes weight loss, but safety concerns like gastrointestinal issues, biliary disease, and potential risks for certain cancers have been investigated through large clinical trials.
  • The safety profile of semaglutide shows mostly mild to moderate side effects such as gastrointestinal disturbances, with no major unexpected safety issues; however, there is a need for careful monitoring of patients with diabetic retinopathy and other conditions due to its potent glucose-lowering effects.
  • Overall, the adverse events associated with semaglutide are similar to those of other drugs in the GLP1RA class, and current evidence does not definitively link it to pancreatic or thyroid cancers, but ongoing research continues to evaluate long-term safety.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Scott Isaacs
@scottisaacsmd · X

The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 135 likes · 31 shares · 17,285 followers View post →
Dr.Madkhali | د. محمد مدخلي
@MMadkhali87 · X

الأمر الثاني: الأدلة العلمية على أمان دواء الاوزمبك والأدوية اللي من نفس المجموعة (GLP-1 agonist ) مبنية على الدراسات السريرية ودراسات ميدانية لخصتها هذه الورقة العلمية واللي راح اختصر اهم النقاط اللي جاءت فيها تابع

May 30, 2022 · 35 likes · 1 share · 15,294 followers View post →
Daniel J Drucker
@DanielJDrucker · X

Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https://t.co/Uyvxkv83le

May 7, 2025 · 34 likes · 7 shares · 34,083 followers View post →
Saúl Sánchez
@SaulNutri · X

Dec 20, 2022 · 29 likes · 11 shares · 107,778 followers View post →
Christopher Snowdon
@cjsnowdon · X

The article includes the obligatory swipe at semaglutide, claiming a risk of pancreatitis that isn't supported by the study she links to. https://t.co/FmuKsAxgMO. https://t.co/ZtwvGZrMha

May 14, 2023 · 19 likes · 64,514 followers View post →
Sociedad SEEN
@sociedadSEEN · X

May 1, 2025 · 15 likes · 6 shares · 17,113 followers View post →

All mentions

❤Elisa❤
@ifoundmetonight · X

@AllieonX Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology https://t.co/vQfFHywJTh

Nov 8, 2025 · 1,794 followers View post →
Peeref
@Peeref1 · X

This article focuses on evaluating the efficacy and safety of semaglutide and tirzepatide in patients with cardiometabolic heart failure with preserved ejection fraction.

Nov 6, 2025 · 172 followers View post →
Chidi E. Omaliko
@ceomaliko1 · X

@ACG_EBGI @AmCollegeGastro @AASLDtweets @LiverFellow @scottisaacsmd @MattiasMandorf1 @DrJavierCrespo @NEJM @PaulYKwo @Medscape @theliverdrALT @AmerGastroAssn @WeitzSportChiro @MonicaTincopa @TheLancetEndo @drsthanus @EASOobesity @NatRevGastroHep @hepatologyforum @CMH_journal @JHepatology 3/8 Study Design

Nov 5, 2025 · 4 likes · 1,321 followers View post →
Maheen Sheraz
@SherazMaheen · X

Excited to share that our systematic review and meta-analysis titled “Efficacy and Safety of Semaglutide on Cardiovascular Outcomes in Patients with Type 2 Diabetes” has been published in Cardiology in Review!

Oct 25, 2025 · 145 followers View post →
HCPLive
@HCPLiveNews · X

On the latest episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, cover the results of the STEP-UP trial, which showed the superior efficacy and safety of semaglutide 7.2 in obesity. Watch now: https://t.co/d3tL6milMw https://t.co/sxED1quUiB

Sep 26, 2025 · 2 likes · 7,538 followers View post →
HCPLive
@hcplivenews.bsky.social · Bluesky

On the latest episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, cover the results of the STEP-UP trial, which showed the superior efficacy and safety of semaglutide 7.2 in obesity. Watch now: www.hcplive.com/view/diabete...

Sep 25, 2025 View post →
Dr. Nazifa Kadery, PharmD, RPh
@dose_of_naz · X

RT @HCPLiveNews: A 30-week trial showed the safety of semaglutide in patients with #schizophrenia, prediabetes, and #obesity. Weekly dosing…

Sep 7, 2025 · 1 share · 255 followers View post →
HCPLive
@HCPLiveNews · X

A 30-week trial showed the safety of semaglutide in patients with #schizophrenia, prediabetes, and #obesity. Weekly dosing reduced HbA1c without affecting mental status. https://t.co/1IBLm8TwZf #mentalhealth https://t.co/xjhRgNEFRW

Sep 6, 2025 · 3 likes · 1 share · 7,530 followers View post →
HCPLive
@hcplivenews.bsky.social · Bluesky

A 30-week trial showed the safety of semaglutide in patients with #schizophrenia, prediabetes, and #obesity. Weekly dosing reduced HbA1c without affecting mental status. www.hcplive.com/view... #mentalhealth

Sep 6, 2025 · 1 like View post →
Luis Zurita G.
@LuisZuritaG · X

Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide ... https://t.co/EG1lxPq96d

Sep 3, 2025 · 6,430 followers View post →
aponia_analytics
@AponiaAnalytics · X

Study Details | Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients | https://t.co/6w10rqq8hu $NVO $LLY $AMGN $AZN $GUTS $TERN $ZLDPF $RHHBY $PFE $SNY $MRK $MBX $GPCR $VANI $VKTX $ZEAL $ASND $HSHPF $RYTM $HIMS https://t.co/50K6CFB2JP

Aug 22, 2025 · 1 like · 5,151 followers View post →
Hernandez Edgar
@Internistacl · X

Cardiovascular outcomes and safety of semaglutide in non-overweight populations with type 2 diabetes: a comparison with dipeptidyl peptidase 4 inhibitors https://t.co/FbDreq25aS

Aug 15, 2025 · 520 followers View post →
aponia_analytics
@AponiaAnalytics · X

Assessing the Safety of Semaglutide and Tirzepatide in Black and Asian Populations: A Narrative Review https://t.co/TSkbRazBOb $NVO $LLY $AMGN $AZN $GUTS $TERN $ZLDPF $RHHBY $PFE $SNY $MRK $MBX $GPCR $VANI $VKTX $ZEAL $ASND $HSHPF $RYTM $HIMS

Aug 4, 2025 · 5,151 followers View post →
Racha Prati
@PratiRacha · X

RT @drbennisahmed: Cardiovascular Outcomes and Safety of Semaglutide in Non-Overweight Populations with Type 2 Diabetes: A Comparison with…

Aug 4, 2025 · 4 shares · 13 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @drbennisahmed: Cardiovascular Outcomes and Safety of Semaglutide in Non-Overweight Populations with Type 2 Diabetes: A Comparison with…

Aug 3, 2025 · 4 shares · 32,525 followers View post →
Muneeb Jan
@manutd91 · X

RT @drbennisahmed: Cardiovascular Outcomes and Safety of Semaglutide in Non-Overweight Populations with Type 2 Diabetes: A Comparison with…

Aug 3, 2025 · 4 shares · 2,088 followers View post →
Antonio Vega
@cardiotoni · X

RT @drbennisahmed: Cardiovascular Outcomes and Safety of Semaglutide in Non-Overweight Populations with Type 2 Diabetes: A Comparison with…

Aug 3, 2025 · 4 shares · 22 followers View post →
Ahmed Bennis MD
@drbennisahmed · X

Cardiovascular Outcomes and Safety of Semaglutide in Non-Overweight Populations with Type 2 Diabetes: A Comparison with Dipeptidyl Peptidase 4 Inhibitors In patients with T2D and BMI <25 kg/m2, semaglutide was associated with a lower 3-year risk of all-cause mortality than https://t.co/GW4e8wZx6R

Aug 3, 2025 · 15 likes · 4 shares · 2,639 followers View post →
quieroserabuela.bsky.social
@quieroserabuela.bsky.social · Bluesky

Ya se conocen algunos de los efectos. pubmed.ncbi.nlm.nih.gov/34305810/

Jul 28, 2025 · 2 likes View post →
TPCH Library
@tpchlibrary · X

Congratulations to #TPCH's S. Parker for their work on the article "Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST)..." https://t.co/UEVrg6RkHa https://t.co/eHHtZDgB9G

Jul 15, 2025 · 216 followers View post →
نشر ورقة علمية #
@AllbynyMws81365 · X

فرصة بحثية للمشاركة (pharmacy ) تتوافق مع شروط (SCFHS) للتقديم ع البورد والرزدنسي تعزيز Cv العنوان: A Systematic Review on the Efficacy and Safety of Semaglutide in Glycemic Control, Weight Reduction, and Cardiovascular Risk Management in Type 2 Diabetes Patients 0547420679 https://t.co/Jm4fgViLyB

Jul 8, 2025 · 89 followers View post →
Zahid
@ZahidRMCF · X

@elgranloteazul4 @Osquiposqui @terrenoviral El ozempic por si mismo no causa efectos adversos y yo hablo con evidencia: Smits MM, Van Raalte DH. Safety of Semaglutide. Front Endocrinol (Lausanne). 2021 Jul 7;12:645563. doi: 10.3389/fendo.2021.645563. Erratum in: Front Endocrinol (Lausanne). 2021 Nov 10;12:786732.

Jun 30, 2025 · 1 like · 14 followers View post →
Luke Nakaji/中島 振一郎@バルサと島巡りと猫と精神医療
@Luke_629 · X

Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia - PubMed https://t.co/kJMYrIxjj5

Jun 13, 2025 · 2 likes · 2,294 followers View post →
Merlina McGovern
@lacalaveracat.bsky.social · Bluesky

There is a ton of research (STEP and SURMOUNT trials) on the efficacy and safety of semaglutide and tirzepatide on obesity. Every day, new trials come out showing improvements to things like fatty liver disease, CVD, kidney disease. Weight stigma and ignorance drives anti-GLP1 sentiment.

May 26, 2025 · 1 like View post →
armando ruiz perez
@aruizperez381 · X

RT @DanielJDrucker: Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https:…

May 7, 2025 · 7 shares · 10 followers View post →
andres
@palacioendocrin · X

RT @DanielJDrucker: Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https:…

May 7, 2025 · 7 shares · 349 followers View post →
Ranganath Muniyappa
@dr_muniyappa · X

RT @DanielJDrucker: Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https:…

May 7, 2025 · 7 shares · 1,090 followers View post →
John Silver
@JohnGolf_CA · X

RT @DanielJDrucker: Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https:…

May 7, 2025 · 7 shares · 31 followers View post →
luis Rodriguez
@luisRod60597844 · X

RT @DanielJDrucker: Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https:…

May 7, 2025 · 7 shares · 23 followers View post →
Edith WK Chow
@EWKChow · X

RT @DanielJDrucker: Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https:…

May 7, 2025 · 7 shares · 19 followers View post →
Naif Almontashiri
@naifalmontashir · X

RT @DanielJDrucker: Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https:…

May 7, 2025 · 7 shares · 24,966 followers View post →
Daniel J Drucker
@DanielJDrucker · X

Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION https://t.co/5154EXUt1z https://t.co/Uyvxkv83le

May 7, 2025 · 34 likes · 7 shares · 34,083 followers View post →
Daniel Drucker
@danieljdrucker.bsky.social · Bluesky

Keeping an eye of the safety of semaglutide #weightloss #T2D #obesity An update on NAION www.nature.com/articles/s41...

May 7, 2025 · 3 likes · 1 share View post →
Cesar Pedraza Hervert
@HervertPedraza · X

RT @sociedadSEEN:

May 3, 2025 · 6 shares · 81 followers View post →
Leonard LN
@leonard49411022 · X

RT @sociedadSEEN:

May 2, 2025 · 6 shares · 238 followers View post →
María Antequera
@mellitus_1 · X

RT @sociedadSEEN:

May 1, 2025 · 6 shares · 1,608 followers View post →
Maria Bernarda Iriarte
@Mbiriarte2203 · X

RT @sociedadSEEN:

May 1, 2025 · 6 shares · 67 followers View post →
Alexis A.
@Alexis_arbra · X

RT @sociedadSEEN:

May 1, 2025 · 6 shares · 216 followers View post →
Lluís Arcalà
@lluis1966 · X

RT @sociedadSEEN:

May 1, 2025 · 6 shares · 2,054 followers View post →
Sociedad SEEN
@sociedadSEEN · X

May 1, 2025 · 15 likes · 6 shares · 17,113 followers View post →
X
@gulvtomat · X

@Palm_DK Tabel 4 i https://t.co/u2uHgRS38n. Tabel 2 i https://t.co/wRszXp1Tyr (corr.) Både frekvens- og alvorlighedsgradsestimater virker undervurderede i dit screenshot, hvis der refereres til anvendelse af medicinsk effektiv dosis.

Apr 9, 2025 · 356 followers View post →
Ana Sanchez Bao
@ana_sanchez_bao · X

RT @sociedadSEEN:

Apr 4, 2025 · 3 shares · 1,094 followers View post →
Juanmarcosgg
@juanmarcosgg · X

RT @sociedadSEEN:

Apr 3, 2025 · 3 shares · 510 followers View post →
Sociedad SEEN
@sociedadSEEN · X

Apr 3, 2025 · 8 likes · 3 shares · 17,113 followers View post →
Akriti Singh
@akritimilisingh · X

RT @singhak_endo: Hot from oven! Until the full results of SURMOUNT 5…@akritimilisingh @docanoopmisra @kamleshkhunti @AmarPut @DrAmbrishMit…

Mar 15, 2025 · 2 shares · 130 followers View post →
Dr. A. K. Singh; MD, DM (Endo)
@singhak_endo · X

Hot from oven! Until the full results of SURMOUNT 5…@akritimilisingh @docanoopmisra @kamleshkhunti @AmarPut @DrAmbrishMithal @AskDrShashank @drmohanv Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide ... https://t.co/mut9gG8QYY

Mar 14, 2025 · 6 likes · 2 shares · 6,367 followers View post →
anoop misra
@docanoopmisra · X

New #Articles in #Diabetes and #Metabolic Syndrome: #Clinical #Research/#Reviews (Ranked 6/244 among Diabetes/Endo journals globally) Comparative efficacy/safety of #semaglutide 2.4 mg and #tirzepatide 5-15 mg in #obesity with or without type 2 #diabetes https://t.co/UQ3hAdKzKK

Mar 9, 2025 · 29,198 followers View post →
Anastasia Dimitrova
@Nessi2201 · X

I have been taking Ozempic (Tirzepatide) for a month now, and I’d like to talk about its effects and possible side effects. While the MHRA publishes detailed reports on the safety of semaglutide-based medications, my personal experience has been extremely positive.

Mar 1, 2025 · 1 like · 8 followers View post →
TF 2
@TonyFauci2 · X

“The American Academy of Ophthalmology has also suggested that a postmarketing surveillance study might better inform physicians and patients about the safety of semaglutide.” $NVO https://t.co/EueK1tLfy5

Feb 18, 2025 · 975 followers View post →
Maso
@Maso_03 · X

@swegpecc @426berke @nabimolm https://t.co/lhzonhBYWr https://t.co/zHrAcxa4HP https://t.co/fC14kEtqbp (Übergewicht ist gefährlicher.)

Feb 7, 2025 · 602 followers View post →
Miodrag Janic
@MiusMaximus · X

RT @AK_Endocrine: Curious about how successful GLP-1 RAs are in syndromic obesity, such as Prader-Willi syndrome? Explore our latest case s…

Jan 24, 2025 · 1 share · 138 followers View post →
Andrijana Koceva
@AK_Endocrine · X

Curious about how successful GLP-1 RAs are in syndromic obesity, such as Prader-Willi syndrome? Explore our latest case series on the long-term efficacy and safety of semaglutide in PWS without concomitant diabetes, even after metabolic surgery.

Jan 24, 2025 · 2 likes · 1 share · 65 followers View post →
McMaster Textbook of Internal Medicine
@mcmtextbook · X

Jan 23, 2025 · 2 likes · 1,319 followers View post →
McMaster Textbook of Internal Medicine
@mcmastertextbook.bsky.social · Bluesky

Jan 23, 2025 View post →
Charlotte
@Charlotte_c0n · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Jan 21, 2025 · 31 shares · 7 followers View post →
JUAN ARIEL JARA GUER
@Tigerariel40 · X

RT @FrontEndocrinol: New Research: Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prade…

Jan 21, 2025 · 1 share · 151 followers View post →
Frontiers - Endocrinology
@FrontEndocrinol · X

New Research: Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review https://t.co/ec9tm0Xip4 #FrontiersIn #Endocrinology

Jan 21, 2025 · 1 like · 1 share · 5,025 followers View post →
malcolm adams
@_malcolmadams · X

@AbrisGains Exactly. https://t.co/iwoVfGiy84

Jan 15, 2025 · 7,080 followers View post →
Lily
@Lily_Chloe1 · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Jan 8, 2025 · 31 shares · 16 followers View post →
Dr.Madkhali | د. محمد مدخلي
@MMadkhali87 · X

RT @MMadkhali87: الأمر الثاني: الأدلة العلمية على أمان دواء الاوزمبك والأدوية اللي من نفس المجموعة (GLP-1 agonist ) مبنية على الدراسات السر…

Jan 7, 2025 · 1 share · 15,294 followers View post →
Muffled
@MuffledBerri · X

There are already well-known long-term side effects of semaglutide (Ozempic), originally used to treat Type2 Diabetes. It is not a "wonder weight loss drug" it has side effects. I have also had friends in hospital due to it, 1 with pancreatic failure. https://t.co/KqJLgcpyAS https://t.co/Vzij6hVxkz https://t.co/dgOTbZdFBZ

Jan 4, 2025 · 1 like · 1,331 followers View post →
DaniReuma
@dani_reuma · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 361 followers View post →
Guy-Stone, MD, MPH
@MPH_Stone · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 600 followers View post →
SLN
@sln__v · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 489 followers View post →
Salman Mehmood
@SalmanMehmood28 · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 33 followers View post →
artem morozov
@artemmo30776735 · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 21 followers View post →
R A Popalzai
@Radion_Popalzai · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 4,615 followers View post →
Edu
@Eduardo03_14 · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 813 followers View post →
Polar Bear
@chaiwat_non · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 111 followers View post →
키에른
@ikasiel · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 28, 2024 · 31 shares · 122 followers View post →
JC Stanford
@JCDarnestown · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 128 followers View post →
Khanchouch Faicel
@KhanchouchFaic1 · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 983 followers View post →
Fernando
@Fernand34482316 · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 15 followers View post →
Zack
@keychupkicap · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 384 followers View post →
Michelle Agurcia
@AMAgurcia · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 2,386 followers View post →
Bongani Mayosi Health Sciences Library (BMHSL)
@uct_bmhsl · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 1,601 followers View post →
Ezeonufo Chukwunonso
@Ezeonufo · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 1,365 followers View post →
Antonio Linares
@drlinaresonline · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 380 followers View post →
dew2kris
@dew2kris · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 283 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 32,525 followers View post →
Dr. Suzana Mantovani
@Tweet_Nutrition · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 4,579 followers View post →
Manoj Mayogi Mishra
@mayogisense · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 573 followers View post →
PpandeloF1
@PpandeloF · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 1,749 followers View post →
Dr.Lama Amer, MD
@Dr_Lama_Amer · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 4,291 followers View post →
Pedgastro
@Isa_CasasG · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 2,432 followers View post →
Dr. Hazim M. Bajri
@hbajri · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 737 followers View post →
Hany Ragy
@Hragy · X

RT @scottisaacsmd: The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 31 shares · 80,360 followers View post →
Scott Isaacs
@scottisaacsmd · X

The safety of #semaglutide in patients with depression and obesity. https://t.co/2blyHOs488 https://t.co/HPrgkG3tkj

Dec 27, 2024 · 135 likes · 31 shares · 17,285 followers View post →
BRETON d'Origine impatrié
@Romaxi45 · X

Efficacy and safety of semaglutide: real-world tertiary care experience from Saudi Arabia - PubMed https://t.co/XnCJ2OeYzc

Dec 15, 2024 · 178 followers View post →
Dragon Slayer aKa Savage JE 20:9
@LashTania · X

Frontiers | Safety of Semaglutide https://t.co/zaKDGSjgss

Dec 11, 2024 · 396 followers View post →
Nick Krontiris
@nick_krontiris · X

Effectiveness and safety of semaglutide in overweight/obese adults with or without type 2 diabetes: A systematic review and meta-analysis (open access) https://t.co/Vr54zoPW3t

Dec 11, 2024 · 1 like · 18,977 followers View post →
Gare Salazar
@GareSalazar3 · X

@tayate2 Non mais je sais lire une étude. Genre rien que celle-ci sur les pancréatites : Hanna Clementine Tan, Oliver Allan Dampil et Maricar Mae Marquez, « Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis », ASEAN.

Nov 30, 2024 · 2 likes · 1,742 followers View post →
Yasser Ad-Dab'bagh
@yasseraddabbagh · X

Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology https://t.co/PlRM1mlWEt

Nov 5, 2024 · 1 like · 71,694 followers View post →
Yasser Ad-Dab'bagh ياسر الدباغ
@yasseraddabbagh.bsky.social · Bluesky

Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology...

Nov 5, 2024 · 1 share View post →
movedoc
@movedoc · X

Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology https://t.co/bmXLHJgUJ1

Nov 5, 2024 · 485 followers View post →
Antoine Julienne
@dr_a_julienne · X

@dr_a90zl @BayesReality @labar0nn3_ En France. Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis https://t.co/0jXHFC8VU7

Oct 6, 2024 · 1,786 followers View post →
RENEGADE
@andi_achilles · X

RT @dokter_kampung: .... keganasan hormon tiroid. Salah satunya studi ini https://t.co/SRLDxH927C

Sep 19, 2024 · 6 shares · 4,217 followers View post →
virag mahorkar
@virag_mahorkar · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 19, 2024 · 45 shares · 19 followers View post →
Neil Floch MD
@NeilFlochMD · X

RT @davearterburn: Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology https://t.co/po9WK…

Sep 19, 2024 · 2 shares · 130,111 followers View post →
Fundación Iberoamericana de Nutrición
@FinutOrg · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 19, 2024 · 45 shares · 4,050 followers View post →
Juan Carlos Obaya
@jcobaya69 · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 857 followers View post →
Iván
@Dockat16 · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 87 followers View post →
Dr Mario HMG
@mgmglobal · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 2,525 followers View post →
Nouf Al hemmadi
@NoufAhmedAlham2 · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 1,273 followers View post →
Neil Floch MD
@NeilFlochMD · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 130,111 followers View post →
Dr Mapachito
@PozosRai · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 239 followers View post →
Luis Alberto Perez
@PerezArr12 · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 324 followers View post →
Adil Rashid MD
@adil_rashidk · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 1,454 followers View post →
Rx Readmore Livemore
@SopitaSirirata1 · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 170 followers View post →
george
@drjorgehv · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 370 followers View post →
Dr.Lama Amer, MD
@Dr_Lama_Amer · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 4,291 followers View post →
felipe marin
@doctorfemaga · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 180 followers View post →
anymzcs
@anymzcs · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 44,268 followers View post →
Powell Kafwanka, MBChB, MSc
@PowellKafwanka · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 18, 2024 · 45 shares · 91 followers View post →
Reuben Elovitz MD
@Concierge__MD · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 17, 2024 · 45 shares · 254 followers View post →
Dr. Michael Alexander
@MichaelAlexandp · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 17, 2024 · 45 shares · 839 followers View post →
JORGE FERNANDEZ
@drjorfer · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 17, 2024 · 45 shares · 1,019 followers View post →
mocchi
@mocchi_ym · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 17, 2024 · 45 shares · 216 followers View post →
Khalid Minhas, MD FACC
@minhaskh · X

RT @scottisaacsmd: STEP 10 assessed the efficacy and safety of #semaglutide for weight management and glycemic control in patients with obe…

Sep 17, 2024 · 45 shares · 11,344 followers View post →
Yasser Ad-Dab'bagh ياسر الدباغ
@yasseraddabbagh.bsky.social · Bluesky

Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology...

Sep 4, 2024 · 1 share View post →
Vigor_Commodity_Rodomontade
@IgorAn9 · X

original publication from PubMed https://t.co/DjkKB40xZH with maps https://t.co/4sdohPkcuu While GLP-1RAs effectively improve glycemic control and cause weight loss, potential safety concerns have arisen over the years. ...

May 21, 2024 · 1,105 followers View post →
Tom Harwood
@tomhfh · X

@DrHoenderkamp Good review of the overall favourable risk/benefit profile here. https://t.co/6VlJpLiN2u

May 13, 2024 · 189,205 followers View post →
celo
@csalles7 · X

@coitadolandiatm @maluparis o efeito é incontestavel, o problema é dps de parar o uso e efeitos contrarios durante ele https://t.co/Z7d2sVvRvC https://t.co/KARUDX5usd

Apr 3, 2024 · 269 followers View post →
iajlbee
@iajlbee · X

@MaryKRe no link or sign of increased risk. On the contrary, an NIH investigation found a *lower* risk of suicidal ideation with Ozempic use. Sources: https://t.co/0352ad9Rp8 https://t.co/YF3hR79rO1 (3/)

Apr 2, 2024 · 336 followers View post →
prosecco mami
@idontbegum · X

Interested in any studies directly geared towards the safety of semaglutide itself? So maybe you can stop falsely calling folks dumb for taking it? Bc the risks are there for ANYONE whether it’s to treat obesity or DMT2/T2D. Muah! https://t.co/PgDo4pEqIt

Feb 17, 2024 · 256 followers View post →
EdenIsHere
@EdenisHere1 · X

RT @dokter_kampung: .... keganasan hormon tiroid. Salah satunya studi ini https://t.co/SRLDxH927C

Feb 12, 2024 · 6 shares · 1,983 followers View post →
Eric_Dublin
@Dublin2Eric · X

RT @dokter_kampung: .... keganasan hormon tiroid. Salah satunya studi ini https://t.co/SRLDxH927C

Feb 1, 2024 · 6 shares · 2,102 followers View post →
Ajo Ari Sikumbang
@AjoAriSikumbang · X

RT @dokter_kampung: .... keganasan hormon tiroid. Salah satunya studi ini https://t.co/SRLDxH927C

Feb 1, 2024 · 6 shares · 1,983 followers View post →
RENEGADE
@andi_achilles · X

RT @dokter_kampung: .... keganasan hormon tiroid. Salah satunya studi ini https://t.co/SRLDxH927C

Feb 1, 2024 · 6 shares · 4,217 followers View post →
Mang Idik
@dokter_kampung · X

.... keganasan hormon tiroid. Salah satunya studi ini https://t.co/SRLDxH927C

Feb 1, 2024 · 14 likes · 6 shares · 6,108 followers View post →
naluavila
@naluavilag · X

@itskatygarcia @amittelstaedtr https://t.co/ft9CFTBgBr

Jan 31, 2024 · 119 followers View post →
Hope Larkin-Begley
@HopeBegley · X

RT @FluoridePoison: @woodymatters @AMPS_RedUnion @DocAhmadMalik @DuncanSyme @Jikkyleaks @NarfGb @CanningPharm Look at the side effects of S…

Dec 15, 2023 · 4 shares · 2,738 followers View post →
Fish Tank
@FishTanksSuck · X

RT @FluoridePoison: @woodymatters @AMPS_RedUnion @DocAhmadMalik @DuncanSyme @Jikkyleaks @NarfGb @CanningPharm Look at the side effects of S…

Dec 15, 2023 · 4 shares · 677 followers View post →
Yusah Rathur
@YRathur · X

RT @FluoridePoison: @woodymatters @AMPS_RedUnion @DocAhmadMalik @DuncanSyme @Jikkyleaks @NarfGb @CanningPharm Look at the side effects of S…

Dec 15, 2023 · 4 shares · 417 followers View post →
Geoffrey Norman Pain
@FluoridePoison · X

RT @FluoridePoison: @woodymatters @AMPS_RedUnion @DocAhmadMalik @DuncanSyme @Jikkyleaks @NarfGb @CanningPharm Look at the side effects of S…

Dec 15, 2023 · 4 shares · 8,425 followers View post →
Geoffrey Norman Pain
@FluoridePoison · X

@woodymatters @AMPS_RedUnion @DocAhmadMalik @DuncanSyme @Jikkyleaks @NarfGb @CanningPharm Look at the side effects of Semaglutide https://t.co/Fol6yzE81w

Dec 13, 2023 · 7 likes · 4 shares · 8,425 followers View post →
AJ Londono
@flowwithaj · X

@ozcabman @hubermanlab Just another fad weight loss trend that will harm many. I’m sure there is a functional use for a small population somewhere that have no other option. https://t.co/IktoD2QVz2

Dec 4, 2023 · 941 followers View post →
Harmless Frog
@FrogHarmless · X

@Fayazbakhsh @cremieuxrecueil It's not quite as bad as a naive reading of the label warning makes it out. Even if it hypothetically doubles the risk of MTC, the sequelae of obesity are far worse. https://t.co/3A7QWVCANP

Sep 4, 2023 · 504 followers View post →
Intento de pajarera 1
@malditosudoku · X

Posibles efectos adversos de agonistas de GLP-1RA como semaglutida (reportados de forma alarmantemente frecuente por usuarios a largo plazo) Fuente: https://t.co/E2haWEkiRe https://t.co/hTmm7Trdkr https://t.co/sdx7vVST2C

Aug 8, 2023 · 3,617 followers View post →
ELIO_LUCIANO
@capuzzi_luciano · X

@dralicehan @syctong https://t.co/pfXn9gGIcw

May 20, 2023 · 209 followers View post →
Christopher Snowdon
@cjsnowdon · X

The article includes the obligatory swipe at semaglutide, claiming a risk of pancreatitis that isn't supported by the study she links to. https://t.co/FmuKsAxgMO. https://t.co/ZtwvGZrMha

May 14, 2023 · 19 likes · 64,514 followers View post →
Salubrious Life
@Salubriouslife1 · X

https://t.co/3U9GA8VUXO

Apr 28, 2023 · 12 followers View post →
RSmith
@Lehi88 · X

Interesting article on safety of Semaglutide with some oral and subcutaneous info. https://t.co/zFOo4wkVLj

Mar 28, 2023 · 1 like · 341 followers View post →
Harmless Frog
@FrogHarmless · X

@DIY_Tardis @raphaels7 @nicknorwitz @realDaveFeldman @BrianLenzkes I doubt that. So far, to my knowledge, there haven't been any surprise findings with regards to safety. https://t.co/90P2oMxGsF

Jan 15, 2023 · 1 like · 504 followers View post →
Pedro Antonio Galván
@PedroAn34677288 · X

RT @SaulNutri:

Dec 21, 2022 · 11 shares · 24 followers View post →
Mar Reyes
@MareloMr · X

RT @SaulNutri:

Dec 21, 2022 · 11 shares · 108 followers View post →
j3j3nt
@j3j3nt · X

RT @SaulNutri:

Dec 21, 2022 · 11 shares · 100 followers View post →
entrucadadetodo
@entrucadadetod2 · X

RT @SaulNutri:

Dec 21, 2022 · 11 shares · 96 followers View post →
Alej.Lopez
@lopz92 · X

RT @SaulNutri:

Dec 21, 2022 · 11 shares · 309 followers View post →
Enríquez-Rábago
@joseEnr999 · X

RT @SaulNutri:

Dec 20, 2022 · 11 shares · 120 followers View post →
Christian Habib ®
@iSGLT2 · X

RT @SaulNutri:

Dec 20, 2022 · 11 shares · 32 followers View post →
Dr. Elvis González (INTENSIVISTA)
@elvisparaguay · X

RT @SaulNutri:

Dec 20, 2022 · 11 shares · 205 followers View post →
Fer Fer Filo
@_nosaboescribir · X

RT @SaulNutri:

Dec 20, 2022 · 11 shares · 7 followers View post →
Rafael Radaeli
@rfradaeli · X

RT @SaulNutri:

Dec 20, 2022 · 11 shares · 382 followers View post →
Sergio Zapata
@serzaparin · X

RT @SaulNutri:

Dec 20, 2022 · 11 shares · 315 followers View post →
Saúl Sánchez
@SaulNutri · X

Dec 20, 2022 · 29 likes · 11 shares · 107,778 followers View post →
BowTiedLoon | Degen Island Physician
@BowTiedLoon · X

@BowTiedFawn @DoctorAnarchist @BowTiedUM Hmm increased HR is known side effect apparently https://t.co/VTvqtm8bgo. (Thyroid cancer only observed in animals so far) https://t.co/GE4KIzuJtr

Oct 26, 2022 · 3 likes · 10,948 followers View post →
Deedy
@deedydas · X

3/5 Only 7% faced minor side-effects (vs 3% placebo). "semaglutide induces mostly mild and transient gastrointestinal disturbances, and increases the risk of cholelithiasis. No major safety concerns have arisen to date" https://t.co/cGx2iXd4RW

Oct 15, 2022 · 2 likes · 208,463 followers View post →
Rajamani Karunanithi
@drknithi · X

https://t.co/g4SVOOoyDH

Oct 7, 2022 · 511 followers View post →
Dr.Madkhali | د. محمد مدخلي
@MMadkhali87 · X

الأمر الثاني: الأدلة العلمية على أمان دواء الاوزمبك والأدوية اللي من نفس المجموعة (GLP-1 agonist ) مبنية على الدراسات السريرية ودراسات ميدانية لخصتها هذه الورقة العلمية واللي راح اختصر اهم النقاط اللي جاءت فيها تابع

May 30, 2022 · 35 likes · 1 share · 15,294 followers View post →
George Wolf
@GeorgeW05314017 · X

@kevinnbass Even though fairly clean, not taking any chances of messing with my pancreas - diet and exercise will do fine for me - https://t.co/nNxDApEJfo

Apr 22, 2022 · 1 like · 34 followers View post →
Paperbirds_Oncology
@PaperbirdsO · X

New article: Safety of Semaglutide https://t.co/TF8pnEdOcH #kidneycancer #oncology https://t.co/0ZGUvjE2s5

Jul 26, 2021 · 892 followers View post →
Paperbirds_Oncology
@PaperbirdsO · X

New article: Safety of Semaglutide https://t.co/sItMpfdnrv #pancreaticcancer #oncology https://t.co/S45nxN4Jdq

Jul 26, 2021 · 892 followers View post →
Frontiers - Endocrinology
@FrontEndocrinol · X

New Research: Safety of Semaglutide: The glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutaneous and oral… https://t.co/dgzYABehyq #Endocrinology #Endo

Jul 7, 2021 · 5 likes · 5,025 followers View post →